![]() |
市場調查報告書
商品編碼
1625298
2030 年結晶纖維素市場預測:按原料類型、形式、製程、應用、最終用戶和地區進行的全球分析Microcrystalline Cellulose Market Forecasts to 2030 - Global Analysis By Source Type (Wood-based and Non-wood-based), Form, Process, Application, End User and By Geography |
根據 Stratistics MRC 的數據,2024 年全球結晶纖維素 (MCC) 市場規模將達到 9 億美元,預計在預測期內將以 8.3% 的複合年成長率成長,到 2030 年將達到 15 億美元。
結晶纖維素 (MCC) 是精製纖維素,是一種存在於植物細胞壁中的天然聚合物。它是通過將木漿或棉花中的纖維素水解成更小的結晶顆粒而生產的。這些顆粒被加工成精細的白色粉末,用於食品、製藥和化妝品行業。 MCC 具有獨特的性能,如吸濕性、高表面積以及對熱和壓力的穩定性。它在食品中用作填充劑、粘合劑和穩定劑,在藥物中用作錠劑崩壞,並在化妝品中起到增稠和紋理作用。
印度政府預計,到2030年,印度醫藥產業市場規模預計將達到1,300億美元。印度也向200多個國家出口藥品,未來可能會繼續這樣做。
製藥和食品飲料行業的需求不斷擴大
結晶纖維素是製藥工業的重要成分,在錠劑中用作粘合劑、崩壞和填充劑。隨著人口老化和慢性疾病導致全球藥品需求增加,對MCC的需求也增加。由於其穩定性、易於吞嚥和控制釋放,它對於錠劑和膠囊至關重要。此外,隨著藥物傳遞系統變得更加複雜,MCC 擴大融入藥物配方中,以提高生物有效性並控制藥物釋放。
替代品的可用性
單株纖維素 (MCC) 替代品的出現加劇了價格競爭,導致許多產品以更低的價格提供或提高了成本效益比。這種利潤壓力可能會促使製造商轉向更便宜的替代品,從而降低供應商的利潤並降低 MCC 的吸引力,尤其是在成本敏感的市場。此外,更便宜的替代品的出現也可能威脅中小型 MCC 製造商的市場佔有率,因為他們可能難以與更便宜的替代品競爭。
對天然和有機產品的需求不斷成長
結晶纖維素是一種植物來源的天然產品,因其無毒且生物分解性而越來越受歡迎。 MCC 由木漿和棉花製成,符合人們對天然材料日益成長的偏好。 MCC 被認為是一種安全的天然成分,並已成為植物來源產品的熱門選擇。 MCC 的吸引力在食品和製藥行業尤其強勁,天然配方是這些行業的首選,從而推動了市場成長。
潛在的健康問題
結晶纖維素(金屬塗層碳酸鹽)可能會導致某些人胃腸道不適,並被認為會導致消化器官系統出現問題。因此,消費者會避免含有MCC的產品。儘管 MCC 是惰性的,但它在食品、藥品和化妝品中的存在可能會引起注重健康的消費者的擔憂,因為他們更喜歡由易於消化和吸收的材料製成的產品。這可能會降低消費者對 MCC 的信心,尤其是在潔淨標示和天然產品趨勢下。
COVID-19 的影響
COVID-19 大流行擾亂了結晶纖維素 (MCC) 市場,影響了生產、供應鏈和需求。隨著生產放緩和消費者行為轉向必需產品,製藥和食品行業對 MCC 的需求出現波動。然而,由於營養補充劑和增強免疫力食品等健康產品的增加,MCC 對藥品和營養補充劑的需求增加。此外,供應鏈問題導致了採購問題,但隨著製造業的恢復,復甦已經取得進展,隨著對天然和有機材料的興趣增加,需求也趨於穩定。
預計木材領域在預測期內將是最大的
由於對有機、潔淨標示和環保產品的需求不斷成長,預計木質材料在預測期內將以最高水準成長。然而,對用於結晶纖維素生產的木材對環境影響的擔憂,例如森林砍伐和過度捕撈,可能會帶來挑戰,並且存在對使用影響較小或更永續的原料生產結晶纖維素的需求。
預計反應擠出領域在預測期內複合年成長率最高。
預計反應擠出領域在預測期內將出現最高複合年成長率,因為它改善了 MCC 的黏度和流動特性,增加了其在食品、藥品和化妝品領域的多功能性。這使得 MCC 作為增稠劑、穩定劑和乳化劑更加有效。此外,透過改變顆粒尺寸和形狀,可以改善在錠劑和藥物被覆劑等各種基質中的分散性。透過使粒徑更細或更均勻,可以改善藥物控制釋放劑和食品的性能,從而導致這些領域的需求增加。
由於北美在慢性病治療、人口老化和醫療成本上升方面的作用,預計在預測期內將佔據最大的市場佔有率。 FDA 和加拿大衛生署等監管機構已確保其安全性,使其成為藥品製造商的首選輔料。學名藥生產的成長通常需要結晶纖維素等高品質輔料,這正在推動該地區的需求。
在注重健康的消費者的推動下,亞太地區預計在預測期內將保持最高的複合年成長率。 MCC 是一種天然衍生成分,用於低脂乳製品、無麩質烘焙點心、食品和飲料以及加工食品,可在不犧牲品質的情況下增強質地並減少熱量。人們對除了基本營養之外還具有健康益處的機能性食品越來越偏好,這是亞太地區結晶纖維素市場的主要驅動力。
According to Stratistics MRC, the Global Microcrystalline Cellulose Market is accounted for $0.9 billion in 2024 and is expected to reach $1.5 billion by 2030 growing at a CAGR of 8.3% during the forecast period. Microcrystalline cellulose (MCC) is a refined form of cellulose, a natural polymer found in plant cell walls. It is produced by hydrolyzing cellulose from wood pulp or cotton, breaking it down into smaller crystalline particles. These particles are processed into a fine white powder, used in food, pharmaceuticals, and cosmetics industries. MCC has unique properties like moisture absorption, high surface area, and stability under heat and pressure. It is used as a bulking agent, binder, and stabilizer in food products, as well as in pharmaceuticals for tablet disintegration and in cosmetics for thickening and texturizing effects.
According to the Government of India, the Indian pharma industry's market size is expected to reach USD 130 billion by 2030. India has also sent pharmaceutical products to more than 200 countries, and it may do so again in the future.
Growing demand in pharmaceuticals & food and beverage industry
Microcrystalline cellulose is a crucial component in the pharmaceutical industry, used as a binder, disintegrant, and filler in tablet formulations. With the global demand for pharmaceuticals increasing due to an aging population and chronic diseases, MCC demand is also increasing. It is crucial in tablets and capsules for stability, ease of swallowing, and controlled release. Moreover as the focus shifts to advanced drug delivery systems, MCC is being incorporated into formulations to improve bioavailability and control drug release.
Availability of substitutes
The availability of substitutes for monoclonal cellulose (MCC) has led to increased price competition, with many products being offered at lower prices or with better cost-benefit ratios. This pressure on profit margins can lead manufacturers to shift to cheaper alternatives, reducing supplier profit margins and potentially reducing the attractiveness of MCC, especially in cost-sensitive markets. Additionally, the availability of cheaper alternatives could threaten the market share of small- and medium-sized producers of MCC, as they may struggle to compete with more affordable substitutes.
Rising demand for natural and organic products
Microcrystalline cellulose, a natural, plant-derived product, is gaining popularity due to its non-toxic, biodegradable nature. It is derived from wood pulp or cotton, aligning with the growing preference for natural ingredients. MCC is perceived as a safe, natural ingredient, making it a popular choice for plant-based products. Its appeal is particularly strong in the food and pharmaceutical industries, where natural formulations are preferred encouraging the market growth.
Potential health concerns
Microcrystalline Cellulose, or metal-coated carbonate, can cause gastrointestinal distress in some individuals, leading to a perception of digestive issues. This can cause consumers to avoid MCC-containing products. Despite being inert, its presence in food, medications, and cosmetics can raise concerns among health-conscious consumers who prefer products made from digestible or absorbable substances. This could reduce consumer trust in MCC, especially in the context of clean-label and natural product trends.
Covid-19 Impact
The COVID-19 pandemic disrupted the Microcrystalline Cellulose (MCC) market, affecting production, supply chains, and demand. Pharmaceutical and food industries saw fluctuating demand for MCC as production slowed and consumer behaviour shifted toward essential products. However, the rise in health-focused products, such as dietary supplements and immune-boosting foods, boosted demand for MCC in pharmaceuticals and nutraceuticals. Additionally, supply chain challenges led to sourcing issues, but recovery is underway as manufacturing resumes, and demand stabilizes with growing interest in natural and organic ingredients.
The wood-based segment is expected to be the largest during the forecast period
The wood-based is expected to be the largest during the forecast period owing to the driving demand for organic, clean-label, and eco-friendly products. However, concerns about the environmental impact of sourcing wood for microcrystalline cellulose production, such as deforestation and overharvesting, may pose a challenge, driving demand for alternative sources of microcrystalline cellulose using less impactful or more sustainable raw materials.
The reactive extrusion segment is expected to have the highest CAGR during the forecast period
The reactive extrusion segment is expected to have the highest CAGR during the forecast period as it improves the viscosity and flow properties of MCC, making it more versatile in food, pharmaceuticals, and cosmetics. This makes MCC more effective in thickening agents, stabilizers, and emulsifiers. Modified particle size and shape can also enhance its dispersion in various matrices, such as tablets or pharmaceutical coatings. Finer or more uniform particle sizes can enhance performance in controlled drug release and food products, leading to increased demand in these sectors.
North America is anticipated to hold the largest market share during the forecast period due to its role in treating chronic diseases, aging populations, and rising healthcare costs. Regulatory agencies like the FDA and Health Canada ensure its safety, making it a preferred excipient for formulators. The growth in generic drug production, which often requires high-quality excipients like microcrystalline cellulose further, boosts demand in the region.
Asia Pacific is expected to hold the highest CAGR over the forecast period driven by health-conscious consumers. MCC, a naturally derived ingredient, is used in low-fat dairy, gluten-free baked goods, beverages, and processed foods to enhance texture and reduce calorie content without compromising quality. The growing preference for functional foods with health benefits beyond basic nutrition is a key driver of the microcrystalline cellulose market in APAC.
Key players in the market
Some of the key players in Microcrystalline Cellulose market include Accent Microcell, Ankit Pulps, Apollo Scientific Ltd, Asahi Kasei Corporation, Blanver, Chemfield Cellulose, DFE Pharma, DuPont, Fengchen Group Co., Ltd., Foodchem International Corporation, Godavari Biorefineries LTD, International Flavors & Fragrances Inc, JRS PHARMA, Roquette Freres, SEPPIC and VWR International, LLC
In December 2024, Asahi Kasei has received governmental support for the expansion of its manufacturing capacity for cell frames and membranes of alkaline water electrolyzers for the production of green hydrogen at its plant site in Kawasaki, Japan.
In November 2024, Chiome Bioscience Inc. and Asahi Kasei Pharma Corporation announced that they have entered into an exclusive license agreement to develop and commercialize Chiome's humanized anti-CX3CR1 antibody (hereinafter referred to "PFKR" as Chiome's project code), currently in the preclinical stage.
In November 2024, DuPont announced the launch of Tyvek(R) with Renewable Attribution (RA), an extension of the existing portfolio of Tyvek(R) products for healthcare packaging that offers a significantly reduced carbon footprint, helping to enable more sustainable healthcare packaging.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.